Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: J Allergy Clin Immunol. 2021 Feb 4;147(5):1732–1741.e1. doi: 10.1016/j.jaci.2021.01.021

Table 4.

Global differences in average olfactory measures and CRS-specific measures across the 10 Clusters

Cluster Test statistic
Olfactory measures: 1 2 3 4 5 6 7 8 9 10
Total TDI score 26.08 (10.43) 18.17 (10.03) 28.57 (6.67) 30.78 (5.45) 20.48 (9.11) 21.53 (10.25) 25.03 (8.22) 26.14 (9.04) 18.90 (9.63) 17.13 (7.64) F=7.12**
Threshold (T) score 5.67 (3.27) 2.77 (2.77) 6.11 (2.87) 6.59 (2.80) 3.13 (2.82) 3.94 (3.12) 4.66 (2.39) 4.41 (2.97) 2.70 (2.41) 2.53 (2.11) F=6.05**
Discrimination (D) score 10.50 (4.06) 7.60 (3.92) 11.00 (2.56) 11.51 (2.18) 8.80 (3.76) 9.41 (3.65) 9.88 (2.75) 10.56 (3.41) 7.60 (2.79) 7.27 (2.40) F=4.63**
Identification (I) score 9.92 (3.94) 7.80 (4.40) 11.45 (2.88) 12.68 (1.96) 8.55 (3.93) 8.19 (4.60) 10.50 (4.24) 11.19 (3.94) 8.60 (4.83) 7.33 (4.17) F=5.88**
QOD-NS 7.75 (6.65) 15.40 (13.42) 6.50 (7.49) 5.38 (8.02) 14.85 (13.37) 8.56 (8.49) 9.00 (9.49) 10.88 (11.66) 21.80 (14.94) 17.33 (8.67) F=4.57**
OCES Total 2.00 (1.73) 5.67 (3.92) 1.60 (2.86) 0.45 (0.83) 4.22 (3.93) 3.62 (3.99) 4.00 (2.00) 6.50 (5.00) 4.00 (5.29) 6.20 (2.78) F=7.07**
CRS-specific measures:
LM-CT total score 14.13 (5.59) 14.85 (4.39) 10.07 (6.08) 10.00 (3.47) 14.47 (5.79) 12.04 (5.85) 13.71 (3.82) 15.45 (5.72) 14.00 (7.65) 17.00 (3.98) F=2.02*
OC Anterior (%) 38.67 (29.74) 62.69 (31.14) 47.43 (32.20) 38.00 (16.52) 61.55 (30.38) 54.13 (34.44) 46.14 (26.28) 51.36 (35.55) 58.33 (34.02) 78.71 (27.69) F=1.33
OC Middle (%) 47.33 (31.53) 63.77 (29.86) 48.43 (32.68) 85.67 (5.51) 65.00 (31.67) 62.96 (26.99) 55.57 (23.05) 53.00 (32.59) 72.00 (23.43) 85.64 (20.80) F=1.98*
OC Posterior (%) 56.00 (32.74) 74.85 (22.90) 52.71 (30.90) 89.67 (9.07) 68.00 (30.04) 67.71 (29.33) 54.43 (24.54) 61.27 (33.86) 77.33 (34.96) 85.93 (22.13) F=1.72
LK Endoscopy total score 5.63 (3.34) 8.00 (2.48) 5.93 (4.01) 2.67 (1.16) 7.76 (3.75) 7.07 (3.36) 6.25 (2.92) 7.94 (4.37) 7.33 (3.06) 8.13 (2.92) F=1.38
SNOT-22 total score 43.00 (20.71) 54.79 (25.16) 45.00 (19.05) 59.67 (26.65) 54.35 (28.34) 44.84 (22.21) 44.85 (43.50) 47.88 (17.96) 63.80 (13.33) 55.60 (18.20) F=0.95
CRS subtypes:
No AERD (N = 109; 85.2%) 8 (100%) 13 (92.9%) 13 (86.7%) 3 (100%) 15 (88.2%) 23 (85.2%) 8 (100%) 14 (87.5%) 2 (40.0%) 10 (66.7%) 2=15.68
AERD (N = 19; 14.8%) 0 (0.0%) 1 (7.1%) 2 (13.3%) 0 (0.0%) 2 (11.8%) 4 (14.8%) 0 (0.0%) 2 (12.5%) 3 (60.0%) 5 (33.3%)
No AFRS (N = 121; 94.5%) 7 (87.5%) 12 (85.7%) 15 (100%) 3 (100%) 17 (100%) 27 (100%) 7 (87.5%) 15 (93.8%) 4 (80.0%) 14 (93.3%) 2=10.92
AFRS (N = 7; 5.5%) 1 (12.5%) 2 (14.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (12.5%) 1 (6.3%) 1 (20.0%) 1 (6.7%)
CRS Patients (N = 128) N=8 N=14 N=15 N=3 N=17 N=27 N=8 N=16 N=5 N=15

N=198. SD, standard deviation; T, Sniffin’ Sticks threshold score; D, Sniffin’ Sticks discrimination score; I, Sniffin’ Sticks identification score; QOD-NS, Questionnaire of Olfactory Dysfunction-Negative Statements; OCES, olfactory cleft endoscopy score; OCES total scores were only available for N=159 patients; OCES total scores were available for N=159 patients. CRS, chronic rhinosinusitis; LM-CT, Lund-Mackay computed tomography; OC, olfactory cleft; LK, Lund-Kennedy; SNOT-22, 22-item SinoNasal Outcome Test; AERD, aspirin exacerbated respiratory disease; AFRS, allergic fungal rhinosinusitis; Analyses based on the subset of patients with CRS with sample sizes in each cluster in the last row.

**

indicates significant differences (p≤0.001) between any two cluster groups using F-test or chi-square (ꭕ2) statistics.